Stylus Medicine Funding: $85M Raised, Series A (2025)
Stylus Medicine is a Biotech company based in Cambridge. It has raised $85M in total funding. Latest round: Series A.
Stylus Medicine funding overview
Stylus Medicine is a Biotech company based in Cambridge. Stylus Medicine has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2025. The round record for Stylus Medicine runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Khosla Ventures, Johnson & Johnson, Eli Lilly, Tachyon Ventures, RA Ventures. 6 distinct backers are named across the disclosed rounds.
Stylus Medicine at a glance
Total raised
$85M
Latest round
Series A
Latest round date
May 2025
Industry
Biotech
Headquarters
Cambridge
Notable investors
RA Capital Management, Khosla Ventures, Johnson & Johnson, Eli Lilly, Tachyon Ventures, RA Ventures
Frequently asked about Stylus Medicine funding
How much has Stylus Medicine raised?
Stylus Medicine has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Stylus Medicine?
RA Capital Management, Khosla Ventures, Johnson & Johnson, Eli Lilly, Tachyon Ventures, RA Ventures are named among the investors backing Stylus Medicine.
What was the latest Stylus Medicine funding round?
The most recent disclosed round is a Series A, announced in May 2025.
Where is Stylus Medicine based?
Stylus Medicine is based in Cambridge.
What sector does Stylus Medicine operate in?
Stylus Medicine is tracked under Biotech from Cambridge, with $85M in disclosed funding.
When did Stylus Medicine last raise?
The last disclosed Stylus Medicine round closed in May 2025 at Series A.
Totals shown for Stylus Medicine aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
